Cargando…

Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin

BACKGROUND: DNA ligases are crucial for DNA repair and cell replication since they catalyze the final steps in which DNA breaks are joined. DNA Ligase III (LIG3) exerts a pivotal role in Alternative-Non-Homologous End Joining Repair (Alt-NHEJ), an error-prone DNA repair pathway often up-regulated in...

Descripción completa

Detalles Bibliográficos
Autores principales: Caracciolo, Daniele, Juli, Giada, Riillo, Caterina, Coricello, Adriana, Vasile, Francesca, Pollastri, Sara, Rocca, Roberta, Scionti, Francesca, Polerà, Nicoletta, Grillone, Katia, Arbitrio, Mariamena, Staropoli, Nicoletta, Caparello, Basilio, Britti, Domenico, Loprete, Giovanni, Costa, Giosuè, Di Martino, Maria Teresa, Alcaro, Stefano, Tagliaferri, Pierosandro, Tassone, Pierfrancesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588242/
https://www.ncbi.nlm.nih.gov/pubmed/36273153
http://dx.doi.org/10.1186/s12967-022-03705-z
_version_ 1784814085800460288
author Caracciolo, Daniele
Juli, Giada
Riillo, Caterina
Coricello, Adriana
Vasile, Francesca
Pollastri, Sara
Rocca, Roberta
Scionti, Francesca
Polerà, Nicoletta
Grillone, Katia
Arbitrio, Mariamena
Staropoli, Nicoletta
Caparello, Basilio
Britti, Domenico
Loprete, Giovanni
Costa, Giosuè
Di Martino, Maria Teresa
Alcaro, Stefano
Tagliaferri, Pierosandro
Tassone, Pierfrancesco
author_facet Caracciolo, Daniele
Juli, Giada
Riillo, Caterina
Coricello, Adriana
Vasile, Francesca
Pollastri, Sara
Rocca, Roberta
Scionti, Francesca
Polerà, Nicoletta
Grillone, Katia
Arbitrio, Mariamena
Staropoli, Nicoletta
Caparello, Basilio
Britti, Domenico
Loprete, Giovanni
Costa, Giosuè
Di Martino, Maria Teresa
Alcaro, Stefano
Tagliaferri, Pierosandro
Tassone, Pierfrancesco
author_sort Caracciolo, Daniele
collection PubMed
description BACKGROUND: DNA ligases are crucial for DNA repair and cell replication since they catalyze the final steps in which DNA breaks are joined. DNA Ligase III (LIG3) exerts a pivotal role in Alternative-Non-Homologous End Joining Repair (Alt-NHEJ), an error-prone DNA repair pathway often up-regulated in genomically unstable cancer, such as Multiple Myeloma (MM). Based on the three-dimensional (3D) LIG3 structure, we performed a computational screening to identify LIG3-targeting natural compounds as potential candidates to counteract Alt-NHEJ activity in MM. METHODS: Virtual screening was conducted by interrogating the Phenol Explorer database. Validation of binding to LIG3 recombinant protein was performed by Saturation Transfer Difference (STD)—nuclear magnetic resonance (NMR) experiments. Cell viability was analyzed by Cell Titer-Glo assay; apoptosis was evaluated by flow cytometric analysis following Annexin V-7AAD staining. Alt-NHEJ repair modulation was evaluated using plasmid re-joining assay and Cytoscan HD. DNA Damage Response protein levels were analyzed by Western blot of whole and fractionated protein extracts and immunofluorescence analysis. The mitochondrial DNA (mtDNA) copy number was determined by qPCR. In vivo activity was evaluated in NOD-SCID mice subcutaneously engrafted with MM cells. RESULTS: Here, we provide evidence that a natural flavonoid Rhamnetin (RHM), selected by a computational approach, counteracts LIG3 activity and killed Alt-NHEJ-dependent MM cells. Indeed, Nuclear Magnetic Resonance (NMR) showed binding of RHM to LIG3 protein and functional experiments revealed that RHM interferes with LIG3-driven nuclear and mitochondrial DNA repair, leading to significant anti-MM activity in vitro and in vivo. CONCLUSION: Taken together, our findings provide proof of concept that RHM targets LIG3 addiction in MM and may represent therefore a novel promising anti-tumor natural agent to be investigated in an early clinical setting. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12967-022-03705-z.
format Online
Article
Text
id pubmed-9588242
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-95882422022-10-24 Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin Caracciolo, Daniele Juli, Giada Riillo, Caterina Coricello, Adriana Vasile, Francesca Pollastri, Sara Rocca, Roberta Scionti, Francesca Polerà, Nicoletta Grillone, Katia Arbitrio, Mariamena Staropoli, Nicoletta Caparello, Basilio Britti, Domenico Loprete, Giovanni Costa, Giosuè Di Martino, Maria Teresa Alcaro, Stefano Tagliaferri, Pierosandro Tassone, Pierfrancesco J Transl Med Research BACKGROUND: DNA ligases are crucial for DNA repair and cell replication since they catalyze the final steps in which DNA breaks are joined. DNA Ligase III (LIG3) exerts a pivotal role in Alternative-Non-Homologous End Joining Repair (Alt-NHEJ), an error-prone DNA repair pathway often up-regulated in genomically unstable cancer, such as Multiple Myeloma (MM). Based on the three-dimensional (3D) LIG3 structure, we performed a computational screening to identify LIG3-targeting natural compounds as potential candidates to counteract Alt-NHEJ activity in MM. METHODS: Virtual screening was conducted by interrogating the Phenol Explorer database. Validation of binding to LIG3 recombinant protein was performed by Saturation Transfer Difference (STD)—nuclear magnetic resonance (NMR) experiments. Cell viability was analyzed by Cell Titer-Glo assay; apoptosis was evaluated by flow cytometric analysis following Annexin V-7AAD staining. Alt-NHEJ repair modulation was evaluated using plasmid re-joining assay and Cytoscan HD. DNA Damage Response protein levels were analyzed by Western blot of whole and fractionated protein extracts and immunofluorescence analysis. The mitochondrial DNA (mtDNA) copy number was determined by qPCR. In vivo activity was evaluated in NOD-SCID mice subcutaneously engrafted with MM cells. RESULTS: Here, we provide evidence that a natural flavonoid Rhamnetin (RHM), selected by a computational approach, counteracts LIG3 activity and killed Alt-NHEJ-dependent MM cells. Indeed, Nuclear Magnetic Resonance (NMR) showed binding of RHM to LIG3 protein and functional experiments revealed that RHM interferes with LIG3-driven nuclear and mitochondrial DNA repair, leading to significant anti-MM activity in vitro and in vivo. CONCLUSION: Taken together, our findings provide proof of concept that RHM targets LIG3 addiction in MM and may represent therefore a novel promising anti-tumor natural agent to be investigated in an early clinical setting. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12967-022-03705-z. BioMed Central 2022-10-22 /pmc/articles/PMC9588242/ /pubmed/36273153 http://dx.doi.org/10.1186/s12967-022-03705-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Caracciolo, Daniele
Juli, Giada
Riillo, Caterina
Coricello, Adriana
Vasile, Francesca
Pollastri, Sara
Rocca, Roberta
Scionti, Francesca
Polerà, Nicoletta
Grillone, Katia
Arbitrio, Mariamena
Staropoli, Nicoletta
Caparello, Basilio
Britti, Domenico
Loprete, Giovanni
Costa, Giosuè
Di Martino, Maria Teresa
Alcaro, Stefano
Tagliaferri, Pierosandro
Tassone, Pierfrancesco
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin
title Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin
title_full Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin
title_fullStr Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin
title_full_unstemmed Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin
title_short Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin
title_sort exploiting dna ligase iii addiction of multiple myeloma by flavonoid rhamnetin
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588242/
https://www.ncbi.nlm.nih.gov/pubmed/36273153
http://dx.doi.org/10.1186/s12967-022-03705-z
work_keys_str_mv AT caracciolodaniele exploitingdnaligaseiiiaddictionofmultiplemyelomabyflavonoidrhamnetin
AT juligiada exploitingdnaligaseiiiaddictionofmultiplemyelomabyflavonoidrhamnetin
AT riillocaterina exploitingdnaligaseiiiaddictionofmultiplemyelomabyflavonoidrhamnetin
AT coricelloadriana exploitingdnaligaseiiiaddictionofmultiplemyelomabyflavonoidrhamnetin
AT vasilefrancesca exploitingdnaligaseiiiaddictionofmultiplemyelomabyflavonoidrhamnetin
AT pollastrisara exploitingdnaligaseiiiaddictionofmultiplemyelomabyflavonoidrhamnetin
AT roccaroberta exploitingdnaligaseiiiaddictionofmultiplemyelomabyflavonoidrhamnetin
AT sciontifrancesca exploitingdnaligaseiiiaddictionofmultiplemyelomabyflavonoidrhamnetin
AT poleranicoletta exploitingdnaligaseiiiaddictionofmultiplemyelomabyflavonoidrhamnetin
AT grillonekatia exploitingdnaligaseiiiaddictionofmultiplemyelomabyflavonoidrhamnetin
AT arbitriomariamena exploitingdnaligaseiiiaddictionofmultiplemyelomabyflavonoidrhamnetin
AT staropolinicoletta exploitingdnaligaseiiiaddictionofmultiplemyelomabyflavonoidrhamnetin
AT caparellobasilio exploitingdnaligaseiiiaddictionofmultiplemyelomabyflavonoidrhamnetin
AT brittidomenico exploitingdnaligaseiiiaddictionofmultiplemyelomabyflavonoidrhamnetin
AT lopretegiovanni exploitingdnaligaseiiiaddictionofmultiplemyelomabyflavonoidrhamnetin
AT costagiosue exploitingdnaligaseiiiaddictionofmultiplemyelomabyflavonoidrhamnetin
AT dimartinomariateresa exploitingdnaligaseiiiaddictionofmultiplemyelomabyflavonoidrhamnetin
AT alcarostefano exploitingdnaligaseiiiaddictionofmultiplemyelomabyflavonoidrhamnetin
AT tagliaferripierosandro exploitingdnaligaseiiiaddictionofmultiplemyelomabyflavonoidrhamnetin
AT tassonepierfrancesco exploitingdnaligaseiiiaddictionofmultiplemyelomabyflavonoidrhamnetin